Masuda et al (17) previously reported that mixed IPMN with positive MUC2 expression had a significantly higher prevalence of high-grade dysplasia and invasive IPMC compared with MUC2-negative IPMN. Here, MUC2 is linked to pancreatic intraductal papillary-mucinous neoplasm.